Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

by Takada H, Nishikomori R, Imagawa T, Lheritier K, Preiss R, Patel N, Gattorno M, Kuemmerle-Deschner J, Hachulla P, Bader-Meunier B, Heike T, Hara T, Yokota S
Published 2011-09-01

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

by McCann L, Ozdogan H, Rutkowska-Sak L, Ferrandiz MA, Wulffraat NM, Brik R, Kallinich T, Erguven M, Berkun Y, Constantin T, Quartier P, Horneff G, Brunner H, Ruperto N, Lheritier K, Preiss R, Tseng L, Martini A, Lovell DJ
Published 2011-09-01